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in-line solvent exchange; and (4) HPLC purification, followed by solid-phase formulation of the final product. The synthesis module was operated in the following sequences with numerical references to the figure below. Figure S1 : Schematic of the GE TRACERlab™ FX FN F]fluoride using a solution (0.075M, 0.6 mL) of tetrabutylammonium hydrogencarbonate, pre-loaded into 1 and delivered to the reactor (12).
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3. The reaction mixture (12) was dried azeotropically by addition of 1 mL anhydrous CH 3 CN, pre-loaded into 4, at 85 °C under N 2 flow and vacuum over 8 min, then at 110 °C under N 2 flow and vacuum for 4 min. 4. After heating to 150 °C, nitro precursor (2 mg in 1.5 mL DMSO) pre-loaded into 3 was added to 12. The reactor was sealed via the closure of valve V13, V20 and V24 and the reaction mixture was heated for 15 min. 5. The reaction mixture was then cooled to 50 °C, vented via valves V24 and V25, and diluted with 10 mL of H 2 O, pre-loaded into 5. 6. The contents of reaction vessel were delivered onto an Oasis® HLB Light SPE cartridge (13) (Waters; pre-activated with 5 mL EtOH followed by 10 mL H 2 O) and washed with 5 mL of water from 6 to remove DMSO, unreacted 18 F-fluoride and other impurities. The crude reaction mixture was eluted from the cartridge (13) with 0.8 mL of CH 3 CN from 2 into 14containing 1 mL of water. The contents of 14 were transferred to the HPLC loop via N 2 pressure via a fluid detector, injected onto a semi-preparative column (X-Select HSS T3, 250 × 10.00 mm, 5), and eluted with 45:55 CH 3 CN/20 mM ammonium acetate by volume (pH 6) at a flow rate of 4 mL/min. The eluent was monitored by UV ( = 254 nm) and radiochemical detectors connected in series. 7. A typical semi-preparative HPLC chromatogram is shown in Figure 2 . The fraction containing the major radiochemical product (t R = 19 min) was collected, via valve 18, into a large dilution vessel (15), which was preloaded with 20 mL of sterile water for injection (United States Pharmacopeia (USP); Hospira). into 8, into collection vial 17 followed by 10 mL 0.9% sodium chloride for injection, USP preloaded into 9. 11. The solution was transferred and passed through a 0.22 µm Millipore GV sterilizing filter (EMD Millipore) into a vented sterile 30 mL dose vial (Hospira). Analyses of radioactive mixtures were performed by HPLC with an in-line UV (( = 254 nm) detector in series with a CsI PIN diode radioactivity detector. To determine the identity of [ 18 F]FPEB, aliquots of the formulated product were injected onto an analytical HPLC system using a Novapak C18 column, 150 × 4.6 mm, 4  luted with 45:55 EtOH/water at a flow rate of 1 mL/min, monitored at  = 254 nm. The major radiochemical product was identified as [ 
F]FPEB
The following tests were carried out in accordance with an MGH approved protocol, as per ICH and USP guidelines.
Visual Inspection: The [ 18 F]FPEB dose was clear, colorless, and free of particulate matter.
Radiochemical Identity, Radiochemical Purity, Injectable Mass and Specific Activity: To determine the identity of [ 18 F]FPEB, aliquots of the formulated product were injected onto an analytical HPLC system using a X-Select HSS T3, 150 × 4.6 mm, 3.5  and eluted with 45:55 EtOH/water at a flow rate of 1 mL/min, monitored at  = 254 nm. After completion of the chromatograph, peaks on UV and radioactivity detector were integrated and the radiochemical and chemical purity were determined by the area of integration.
The major radiochemical product was identified as [ 19 F]FPEB and was within ±10% error. The radiochemical purity was >95%. Allowed injectable mass are as follows: ≤3.6 g and ≤0.36g of unknown chemical impurities. Specific activity was determined using standard FPEB specific activity calibration curve. Specific activity must be ≥800 mCi per micromole at time of administration.
Residual Solvent Analysis: Residual solvent assay was performed to verify that residual solvents from in the synthesis and maintenance of the synthesis units are within acceptable limits. Gas chromatography (GC) was used to determine the solvent residue and the results met the following specifications.
DMSO (Class III) <5 mg/mL; Acetone (Class III) <5 mg/mL; Acetonitrile (Class II) <0.4 mg/mL; Ethanol (Class III) <10% v/v ± 10% (formulation agent) pH Assay: The pH of [ 18 F]FPEB was determined by applying a few drops of the dose to pH indicator paper. Match the reference color and the pH value conformed to our release specifications (4.5-8.5).
Sterile Filter Integrity Test: Sterile filter integrity test was performed as per manufacturer specification and the pressure and was ≥ 50psi for the Millipore Millex GV 0.22 µm sterilizing filter.
Radionuclidic ID -photopeak and half-life: Measure the radioactivity of the formulated product at two separated time points. The half-life consistently met our release specifications (105-115 minutes).
Photopeak was determined based on the following protocol:
Introduce small amount of radioactivity of formulated product into gamma spectrometer. Record the spectrum and integrate the areas under the signals of the spectrum. The result was >99.5% emission @511 KeV, 1.022 MeV.
Endotoxin Analysis: Endotoxin analysis was performed on a Charles River Laboratories Endosafe PTS system using a 1:100 dilution. Doses contained ≤ 17.5 EU/mL. Figure S4 , The synthesis module was operated in the following sequences with numerical references to Figure S4 Turn on the gas to mix the DMSO and water solution 100 /7U2R Turn on the Gas to Concentrator 2 100 /6go1V4000A12000o4V4000A0G2R Rinse syringe with water 10000 /1u3R Make sure we are on Water 100 /2u3R Make sure we are set to waste port on SPE 100 AO-2 0.25 Turn off gas at MFC 100 /7u2R Shut Gas valve 10000 /6go6V4000A12000o2V2000A0G11ggo1V4000A12000o6V4000A0G5go6V4000A1200 0o2V4000A0G5G5R "Push diluted solution over SPE, rinse vessel with water and push over SPE" 500000 /6go3V4000A12000o4V4000A0G2o3V4000A12000R "Clean the syringe with acetonitrile, and fill with ACN" 25000 /1U3R Switch Valve to elute FPEB to vial with mobile phase 100 /6o3V4000A12000o2V400D6000o2V200D6000go1V4000A12000o4V4000A0G3go1V4 000A12000o2V2000A0G3R Flush SPE with 1 ml of Acetonitrile then flush with 2 ml of Water 120000 /1u3R Switch back to Waste 
